Loading...
Loading...
If you hold equity in a venture-backed startup, sooner or later you will run into a quiet but consequential piece of securities law: Rule 144. This U.S. Securities and Exchange Commission regulation governs when and how you can resell shares that were never registered with the SEC — a description that fits almost all private company stock. Understanding the rules around Rule 144 private company stock is what separates a clean, legal sale from a transaction that exposes you to securities-law liability.
Whether you exercised options at an early-stage company, received a founder's grant, or bought into a secondary round, your shares are almost certainly 'restricted securities.' That label has real consequences for if, when, and how you can sell. In this guide we combine two perspectives — an institutional investor's and a private wealth manager's — to walk through how the rule works, the relevant holding periods, the conditions you must satisfy, and the realistic options for turning illiquid equity into something you can actually use.
Rule 144 is a 'safe harbor' under the Securities Act of 1933. The default position of U.S. securities law is that you cannot resell securities unless the resale is registered or qualifies for an exemption. Rule 144 provides that exemption for 'restricted' and 'control' securities, setting out a checklist of conditions that — once met — allow you to sell without registering the transaction. The SEC's own overview of Rule 144 is the authoritative starting point, and I'd encourage every shareholder to read it before signing anything.
For Rule 144 private company stock, the rule matters even more than it does for public shares, because there is no public market to absorb your sale. Even when a willing buyer exists — a secondary fund, a family office, or an accredited individual — the transfer must still comply with securities law. Rule 144 is the most common framework used to make such a resale legitimate, which is why it shows up in nearly every secondary transaction involving startup equity.
The rule draws a critical distinction. Restricted securities are those acquired in an unregistered, private transaction — employee option exercises, restricted stock grants, and private placements all qualify. Control securities are those held by an 'affiliate' of the company: an officer, director, or large shareholder in a position to influence management. The same shares can be both restricted and control securities, and affiliates face additional hurdles that ordinary employees do not.
Why does this matter? Because the conditions you must satisfy depend on which category you fall into. A rank-and-file engineer selling vested shares is treated very differently from a founder or a VP who sits close to the company's decision-making. If you are unsure whether you count as an affiliate, that is precisely the kind of question to put to a securities attorney before you market your shares.
The cornerstone of the rule is the holding period. Before you can rely on Rule 144 at all, you must have held the restricted securities for a minimum length of time. The Rule 144 holding period is six months if the issuing company is a 'reporting company' under the Securities Exchange Act of 1934, and a full year if it is a non-reporting company. Because the overwhelming majority of startups are non-reporting, the practical Rule 144 holding period for private company stock is one year.
When does the clock start? Generally, the holding period begins on the date you paid the full purchase price or otherwise fully acquired the securities. For employees, that usually means the exercise date of your options — not the grant date, and not the vesting date. This is a detail I've seen trip people up repeatedly: someone assumes their four-year tenure counts toward the clock, when in fact the period only starts when they actually write the check to exercise. Investor.gov publishes a clear, plain-English explainer on this point that is worth bookmarking.
Meeting the holding period is necessary but not always sufficient. Rule 144 lays out up to five conditions, and how many apply depends on whether you are an affiliate of the issuer:
1. Holding period — satisfied as described above. 2. Current public information — adequate, current information about the issuer must be publicly available. 3. Volume limitations — affiliates may sell only a limited amount within any three-month window. 4. Ordinary brokerage transactions — affiliates must sell in routine 'manner of sale' transactions. 5. Filing a notice on Form 144 — affiliates selling above certain thresholds must file notice with the SEC.
Here is the practical takeaway. Non-affiliates who have satisfied a one-year holding period can generally resell restricted securities free of most of these conditions. Affiliates, by contrast, must continue to satisfy the volume limits, manner-of-sale rules, and notice filing for as long as they remain affiliates. For most startup employees who have already left the company, the path is simpler than it looks — but the 'current public information' requirement is where private shares get complicated.
Here is the catch for private companies: the 'current public information' condition is built for public issuers that file regular reports. A pre-IPO startup, by definition, does not. As a result, Rule 144 startup shares are rarely sold cleanly on an open market the way public shares are. In practice, holders rely on a combination of the rule and company cooperation — for example, the company providing the required financial information, or the sale being structured through a company-sanctioned secondary program or tender offer.
Layered on top of all this are the company's own transfer restrictions. Most startups impose a right of first refusal, board-approval requirements, and outright transfer prohibitions in their bylaws and stock agreements. Even if you satisfy every element of Rule 144, you may still be contractually barred from selling without the company's consent. This is the core problem facing stock and option holders: the legal right to sell and the practical ability to sell are two very different things. That is why Rule 144 startup shares typically change hands through company-sanctioned channels rather than private side deals.
Consider a concrete example. Suppose you exercised 10,000 options at a $2.00 strike eighteen months ago, and a secondary buyer now offers $12.00 per share. You are no longer with the company and you are not an affiliate. You have cleared the one-year holding period, so the holding-period condition is met. Whether you can actually close depends on the company's right of first refusal and whether it will provide the information a buyer needs to get comfortable. When you sell Rule 144 private company stock through a secondary transaction like this, the buyer's counsel will almost always require a legal opinion confirming the exemption applies.
Now contrast that with a current VP who is clearly an affiliate. Even after the holding period, that person must respect the volume limitations, sell through ordinary brokerage channels, and file a Form 144 once they cross the threshold. The same underlying shares carry a heavier compliance burden simply because of the seller's relationship to the company. Two people, identical stock, very different rules.
Even when the mechanics line up, a single-company position is a risk in itself. The hard truth, well documented by venture data, is that most startups do not produce life-changing exits, and a concentrated bet on one company's equity can swing from paper fortune to zero. Clearing the Rule 144 hurdle solves the legal question; it does not solve the diversification question. Before you sell — or decide not to — it is worth thinking carefully about whether to buy your equity in the first place and what you would do with the proceeds.
This is where some holders look at alternatives to an outright sale. Equity pooling, for instance, lets employees and shareholders across multiple startups contribute their shares into a diversified vehicle, trading single-company exposure for a basket of high-growth companies. It is a different answer to the same underlying problem that Rule 144 private company stock holders face: how to responsibly convert illiquid, concentrated equity into something more balanced. If you want the mechanics, our introduction to equity pooling lays out how the structure works.
None of this removes the need for careful planning. Whichever route you choose — a Rule 144 secondary sale, a company tender offer, or pooling — the tax treatment, the holding-period math, and the company's transfer rules all interact. A short conversation with a securities attorney and a tax advisor early in the process can save you from an expensive mistake later.
Rule 144 private company stock will not stay frozen forever, but unlocking it takes more than patience. You need to clear the holding period, satisfy the applicable conditions, navigate the current-information requirement that trips up private shares, and respect your company's transfer restrictions. Get those pieces right and you have a legitimate, defensible path to liquidity. Get them wrong and a well-intentioned sale can become a legal headache.
If you are weighing your options, start by understanding exactly what you hold and what restrictions apply, then map out your goals — liquidity, diversification, or both. You can review common questions on our FAQ, and when you are ready to explore turning a concentrated position into a diversified one, you can get an offer from Aption to see what your equity could look like as part of a pooled portfolio.
Disclaimer: The author name used in this article may be a pen name or pseudonym and is used for illustrative and editorial purposes only. This article is for informational purposes only and does not constitute investment, tax, or legal advice. Consult qualified professionals before making financial decisions. Rule 144 is a complex regulation whose application depends on your specific facts and circumstances; consult a qualified securities attorney and tax professional before selling any restricted securities.
Daniel is a former venture capital partner and startup equity strategist with over 15 years of experience advising founders, employees, and institutional investors on equity structures, liquidity events, and portfolio construction.